Federal contract award
HHSN275201700002C
IGF::OT::IGF DATA COORDINATING CENTER FOR THE BEST PHARMACEUTICALS FOR CHILDREN ACT
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NICHD |
| NAICS | 541711 |
| PSC | AN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | COST PLUS FIXED FEE |
| Obligations | $66.0M |
| Current contract value | $66.0M |
| Potential contract value / ceiling | $69.5M |
| Start date | Jul 28, 2017 |
| Current end date | May 28, 2027 |
| Potential end date | Jun 28, 2027 |
| Latest award activity | Sep 2, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 36 of 36 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Sep 2, 2026 | P00035 | $-8.4K | DATA COORDINATING CENTER FOR THE BEST PHARMACEUTICALS FOR CHILDREN ACT |
| Jul 20, 2026 | P00034 | $0 | EO14398 - DATA COORDINATING CENTER FOR THE BEST PHARMACEUTICALS FOR CHILDREN ACT |
| May 29, 2026 | P00033 | $4.7M | DATA COORDINATING CENTER FOR THE BEST PHARMACEUTICALS FOR CHILDREN ACT |
| May 27, 2026 | P00032 | $0 | DATA COORDINATING CENTER FOR THE BEST PHARMACEUTICALS FOR CHILDREN ACT |
| Aug 28, 2025 | P00031 | $-45.0K | DATA COORDINATING CENTER FOR THE BEST PHARMACEUTICALS FOR CHILDREN ACT |
| May 27, 2025 | P00030 | $6.0M | DATA COORDINATING CENTER FOR THE BEST PHARMACEUTICALS FOR CHILDREN ACT |
| May 22, 2025 | P00029 | $0 | EOI::EO: RADICAL TRANSPARENCY ABOUT WASTEFUL SPENDING::EOI BILATERAL MODIFICATION TO DESCOPE WORK TO REFLECT COST SAVINGS IN FY25 --- DATA COORDINATING CENTER FOR THE BEST PHARMACEUTICALS FOR CHILDREN ACT |
| Dec 17, 2024 | P00028 | $0 | DATA COORDINATING CENTER FOR THE BEST PHARMACEUTICALS FOR CHILDREN ACT |
| Jul 25, 2024 | P00027 | $-107.1K | DATA COORDINATING CENTER FOR THE BEST PHARMACEUTICALS FOR CHILDREN ACT |
| May 29, 2024 | P00026 | $7.4M | DATA COORDINATING CENTER FOR THE BEST PHARMACEUTICALS FOR CHILDREN ACT |
| Sep 21, 2023 | P00025 | $725.4K | DATA COORDINATING CENTER FOR THE BEST PHARMACEUTICALS FOR CHILDREN ACT |
| Aug 10, 2023 | P00024 | $-76.1K | IPP DATA COORDINATING CENTER FOR THE BEST PHARMACEUTICALS FOR CHILDREN ACT |
| May 12, 2023 | P00023 | $7.1M | IPP DATA COORDINATING CENTER FOR THE BEST PHARMACEUTICALS FOR CHILDREN ACT |
| Jul 7, 2022 | P00022 | $0 | IPP DATA COORDINATING CENTER FOR THE BEST PHARMACEUTICALS FOR CHILDREN ACT |
| May 27, 2022 | P00021 | $6.9M | IPP DATA COORDINATING CENTER FOR THE BEST PHARMACEUTICALS FOR CHILDREN ACT |
| May 5, 2022 | P00020 | $600.0K | IPP DATA COORDINATING CENTER FOR THE BEST PHARMACEUTICALS FOR CHILDREN ACT |
| Feb 25, 2022 | P00019 | $0 | IPP DATA COORDINATING CENTER FOR THE BEST PHARMACEUTICALS FOR CHILDREN ACT |
| Feb 23, 2022 | P00018 | $-98.2K | EO- 14042 -DATA COORDINATING CENTER FOR THE BEST PHARMACEUTICALS FOR CHILDREN ACT |
| Nov 18, 2021 | P00017 | $0 | EO14042 -DATA COORDINATING CENTER FOR THE BEST PHARMACEUTICALS FOR CHILDREN ACT |
| Sep 23, 2021 | P00016 | $0 | DATA COORDINATING CENTER FOR THE BEST PHARMACEUTICALS FOR CHILDREN ACT |
| May 27, 2021 | P00015 | $6.3M | DATA COORDINATING CENTER FOR THE BEST PHARMACEUTICALS FOR CHILDREN ACT |
| May 7, 2021 | P00014 | $628.3K | DATA COORDINATING CENTER FOR THE BEST PHARMACEUTICALS FOR CHILDREN ACT |
| Sep 22, 2020 | P00013 | $1.7M | DATA COORDINATING CENTER FOR THE BEST PHARMACEUTICALS FOR CHILDREN ACT |
| Sep 1, 2020 | P00012 | $0 | DATA COORDINATING CENTER FOR THE BEST PHARMACEUTICALS FOR CHILDREN ACT |
| Jun 29, 2020 | P00011 | $6.1M | DATA COORDINATING CENTER FOR THE BEST PHARMACEUTICALS FOR CHILDREN ACT |
| Jun 24, 2020 | P00010 | $608.8K | DATA COORDINATING CENTER FOR THE BEST PHARMACEUTICALS FOR CHILDREN ACT |
| Jul 29, 2019 | P00009 | $5.9M | DATA COORDINATING CENTER FOR THE BEST PHARMACEUTICALS FOR CHILDREN ACT |
| Jul 16, 2019 | P00007 | $0 | DATA COORDINATING CENTER FOR THE BEST PHARMACEUTICALS FOR CHILDREN ACT |
| Jul 16, 2019 | P00008 | $107.1K | DATA COORDINATING CENTER FOR THE BEST PHARMACEUTICALS FOR CHILDREN ACT |
| Sep 17, 2018 | 6 | $317.5K | IGF::OT::IGF DATA COORDINATING CENTER FOR THE BEST PHARMACEUTICALS FOR CHILDREN ACT |
| Sep 14, 2018 | 5 | $-317.5K | IGF::OT::IGF DATA COORDINATING CENTER FOR THE BEST PHARMACEUTICALS FOR CHILDREN ACT |
| Sep 7, 2018 | 4 | $580.0K | IGF::OT::IGF DATA COORDINATING CENTER FOR THE BEST PHARMACEUTICALS FOR CHILDREN ACT |
| Jul 27, 2018 | 3 | $5.6M | IGF::OT::IGF DATA COORDINATING CENTER FOR THE BEST PHARMACEUTICALS FOR CHILDREN ACT |
| Apr 10, 2018 | 2 | $0 | IGF::OT::IGF DATA COORDINATING CENTER FOR THE BEST PHARMACEUTICALS FOR CHILDREN ACT |
| Sep 28, 2017 | 1 | $180.3K | IGF::OT::IGF DATA COORDINATING CENTER FOR THE BEST PHARMACEUTICALS FOR CHILDREN ACT |
| Jul 28, 2017 | 0 | $5.3M | IGF::OT::IGF DATA COORDINATING CENTER FOR THE BEST PHARMACEUTICALS FOR CHILDREN ACT |
Estimated positioning window
Oct 25, 2026 – Jan 23, 2027
Recompete signal: . Rule-based research score; positioning dates are estimates.
80/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 80/100. Available recorded signals: 75 points.
- Contract end 2027-06-28 (246 days from calculation)
- +35 points
- 5 historical awards in this buyer and category group
- +15 points
- 36 recorded award transactions
- +10 points
- Latest award action: 2026-09-02
- +5 points
- Parent award identifier recorded
- +0 points
- Solicitation identifier recorded
- +10 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-10-25 10:18:04.631876+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Oct 25, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Verify whether remaining options may extend performance beyond the current end date.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.